Dr. Adam Woolfe, computational biologist and bioinformatics R&amp;D leader at Bio-Rad, discusses building bioinformatics tools for scientific instruments and new approaches to antibody discovery.<br>The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.<br>https://www.bioinformaticscro.com/

Adam Woolfe - antibody discovery technology

The Bioinformatics CRO Podcast

Welcome to the The Bioinformatics CRO Podcast. I'm your host, Grant Bellegarde. Today, I'm joined by Dr. Adam Wolfe, a computational biologist and bioinformatics R&D leader at BioRad. Adam's career has taken him from comparative genomics and gene regulation to single-cell technologies, antibody discovery, and computational immunology. His recent work includes Paraplume, a sequence-based approach to predicting antibody binding regions using protein language models. We'll discuss what he's working on today, the

path that brought him there, and what he has learned about building a career at the intersection of biology and computation. Adam, welcome to the podcast. Adam Wolfe, MD, PhD Nice to see you again, Grant. Thanks for inviting me here. Adam Werner So for listeners meeting you for the first time, how would you describe your current role and the questions you're responsible for? Adam Wolfe, MD, PhD Okay, so my role is basically to develop the bioinformatics tools, pipelines, and software necessary to develop our instruments and also to support the customers that use our instruments.

Adam Wolfe, MD, PhD Adam Wolfe, MD, PhD Things like digital PCR, PCR thermocyclers, gel electrophoresis machines. Adam Wolfe, MD, PhD If you have worked in a lab, and I guess a lot of the people who do biomatics have not, but if you, the people who make your data will probably know about BioRad because it is such a big company. Adam Wolfe, MD, PhD So I'm based in Paris Front or just outside Paris Front.

Adam Wolfe, MD, PhD And how I ended up here was basically that I used to work in a startup company called Saber Bio. Adam Wolfe, MD, PhD So I'm now part of the Saber Bio project in BioRad, but Saber Bio was a startup company a couple of years ago.

Adam Woolfe - antibody discovery technology

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Adam Woolfe - antibody discovery technology

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.